HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Morales Selected Research

cytolethal distending toxin

10/2020Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
1/2017Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
5/2015Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
1/2015Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.
10/2012Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome.
9/2011Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Morales Research Topics

Disease

10Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2021 - 06/2009
3Diarrhea
11/2019 - 01/2015
2Constipation
01/2022 - 09/2010
2Infections
10/2020 - 05/2015
2Gastroenteritis
05/2015 - 01/2015
1Systemic Scleroderma (Systemic Sclerosis)
06/2021
1Appendicitis
01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2019
1Abdominal Pain (Pain, Abdominal)
11/2019
1Obesity
03/2016
1Fetal Death
04/2005
1Fetofetal Transfusion (Twin Transfusion Syndrome)
04/2005

Drug/Important Bio-Agent (IBA)

6VinculinIBA
06/2021 - 01/2015
6cytolethal distending toxinIBA
10/2020 - 09/2011
4Biomarkers (Surrogate Marker)IBA
06/2021 - 01/2015
4AntibodiesIBA
06/2021 - 01/2015
4Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 09/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2016
2Lactulose (Duphalac)FDA LinkGeneric
01/2022 - 09/2010
1AutoantibodiesIBA
10/2020
1Formaldehyde (Formol)FDA Link
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1ParaffinIBA
01/2020
1LDL CholesterolIBA
03/2016
1Insulin (Novolin)FDA Link
03/2016
1Rifaximin (L 105)FDA Link
09/2010
1NeomycinFDA LinkGeneric
09/2010
1tegaserod (Zelnorm)FDA Link
06/2009
1Erythromycin (Erycette)FDA LinkGeneric
06/2009

Therapy/Procedure

1Appendectomy
01/2020
1Therapeutics
01/2020
1Aftercare (After-Treatment)
06/2009
1Lasers (Laser)
04/2005
1Laser Therapy (Surgery, Laser)
04/2005
1Light Coagulation
04/2005